Efficacy of Mogamulizumab by Prior Systemic Therapy in Patients With Previously Treated Cutaneous T-Cell Lymphoma: Post Hoc Analysis From the Phase 3 MAVORIC Study

被引：0
|
作者：
Scarisbrick, J. [1 ]
Zinzani, P. L. [2 ]
Horwitz, S. [3 ]
Kim, Y. H. [4 ]
Moskowitz, A. J. [3 ]
Porcu, P. [5 ]
Leoni, M. [6 ]
Dwyer, K. [6 ]
Sun, W. [6 ]
Nikonova, E. [7 ]
Bagot, M. [8 ]
机构：
[1] Univ Hosp Birmingham, Birmingham, W Midlands, England
[2] Univ Bologna, Inst Hematol Seragnoli, Bologna, Italy
[3] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[4] Stanford Univ, Stanford, CA 94305 USA
[5] Thomas Jefferson Univ, Philadelphia, PA 19107 USA
[6] Kyowa Kirin Pharmaceut Dev Inc, Princeton, NJ USA
[7] Kyowa Kirin Inc, Bedminster, NJ USA
[8] Univ Paris 07, Inserm U976, Hop St Louis, AP HP, Paris, France
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2019年 / 185卷
关键词：
Cutaneous T-cell Lymphoma; Mogamulizumab; Mycosis Fungoides; Sezary syndrome;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
BSH19-PO-0
引用
收藏
页码：94 / 94
页数：1
相关论文
共 43 条
  • [21] A phase II placebo-controlled study of photodynamic therapy with topical hypericin and visible light irradiation in the treatment of cutaneous T-cell lymphoma and psoriasis
    Rook, Alain H.
    Wood, Gary S.
    Duvic, Madeleine
    Vonderheid, Eric C.
    Tobia, Alfonso
    Cabana, Bernard
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2010, 63 (06) : 984 - 990
  • [22] Analysis of clinical and serologic predictors of response to extracorporeal photopheresis therapy in cutaneous T-cell lymphoma patients
    Sun, Lillian D.
    Polly, Samantha
    Ko, Jennifer S.
    Ricci, Kristin
    Hsi, Eric D.
    Cooper, Kevin D.
    Fernandez, Anthony P.
    PHOTODERMATOLOGY PHOTOIMMUNOLOGY & PHOTOMEDICINE, 2022, 38 (06) : 600 - 603
  • [23] Real-World Treatment Patterns and Clinical Outcomes With Brentuximab Vedotin or Other Standard Therapies in Patients With Previously Treated Cutaneous T-Cell Lymphoma in the United States
    Barta, Stefan K.
    Liu, Nicholas
    DerSarkissian, Maral
    Chang, Rose
    Ye, Mingchen
    Duh, Mei Sheng
    Surinach, Andy
    Fanale, Michelle
    Yu, Kristina S.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 (02) : e21 - e32.e4
  • [24] Phase I and pharmacokinetic study of the oral histone deacetylase inhibitor vorinostat in Japanese patients with relapsed or refractory cutaneous T-cell lymphoma
    Wada, Hidefumi
    Tsuboi, Ryoji
    Kato, Yukihiko
    Sugaya, Makoto
    Tobinai, Kensei
    Hamada, Toshihisa
    Shimamoto, Takashi
    Noguchi, Kazuo
    Iwatsuki, Keiji
    JOURNAL OF DERMATOLOGY, 2012, 39 (10) : 823 - 828
  • [25] Randomized phase 3 ALCANZA study of brentuximab vedotin vs physician's choice in cutaneous T-cell lymphoma: final data
    Horwitz, Steven M.
    Scarisbrick, Julia J.
    Dummer, Reinhard
    Whittaker, Sean
    Duvic, Madeleine
    Kim, Youn H.
    Quaglino, Pietro
    Zinzani, Pier Luigi
    Bechter, Oliver
    Eradat, Herbert
    Pinter-Brown, Lauren
    Akilov, Oleg E.
    Geskin, Larisa
    Sanches, Jose A.
    Ortiz-Romero, Pablo L.
    Weichenthal, Michael
    Fisher, David C.
    Walewski, Jan
    Trotman, Judith
    Taylor, Kerry
    Dalle, Stephane
    Stadler, Rudolf
    Lisano, Julie
    Bunn, Veronica
    Little, Meredith
    Prince, H. Miles
    BLOOD ADVANCES, 2021, 5 (23) : 5098 - 5106
  • [26] Efficacy and Safety of Topical Hypericin Photodynamic Therapy for Early-Stage Cutaneous T-Cell Lymphoma (Mycosis Fungoides) The FLASH Phase 3 Randomized Clinical Trial
    Kim, Ellen J.
    Mangold, Aaron R.
    DeSimone, Jennifer A.
    Wong, Henry K.
    Seminario-Vidal, Lucia
    Guitart, Joan
    Appel, James
    Geskin, Larisa
    Lain, Edward
    Korman, Neil J.
    Zeitouni, Nathalie
    Nikbakht, Neda
    Dawes, Kenneth
    Akilov, Oleg
    Carter, Joi
    Shinohara, Michi
    Kuzel, Timothy M.
    Piette, Warren
    Bhatia, Neal
    Musiek, Amy
    Pariser, David
    Kim, Youn H.
    Elston, Dirk
    Boh, Erin
    Duvic, Madeleine
    Huen, Auris
    Pacheco, Theresa
    Zwerner, Jeffrey P.
    Lee, Seung Tae
    Girardi, Michael
    Querfeld, Christiane
    Bohjanen, Kimberly
    Olsen, Elise
    Wood, Gary S.
    Rumage, Adam
    Donini, Oreola
    Haulenbeek, Andrea
    Schaber, Christopher J.
    Straube, Richard
    Pullion, Christopher
    Rook, Alain H.
    Poligone, Brian
    JAMA DERMATOLOGY, 2022, 158 (09) : 1031 - 1039
  • [27] Results from a Phase I/II Open-Label, Dose-Finding Study of Pralatrexate and Oral Bexarotene in Patients with Relapsed/Refractory Cutaneous T-cell Lymphoma
    Duvic, Madeleine
    Kim, Youn H.
    Zinzani, Pier Luigi
    Horwitz, Steven M.
    CLINICAL CANCER RESEARCH, 2017, 23 (14) : 3552 - 3556
  • [28] Primary Cutaneous NK/T-cell Lymphoma, Nasal Type and CD56-positive Peripheral T-cell Lymphoma A Cellular Lineage and Clinicopathologic Study of 60 Patients From Asia
    Takata, Katsuyoshi
    Hong, Min-eui
    Sitthinamsuwan, Panitta
    Loong, Florence
    Tan, Soo-Yong
    Liau, Jau-Yu
    Hsieh, Pin-Pen
    Ng, Siok-Bian
    Yang, Sheau-Fang
    Pongpruttipan, Tawatchai
    Sukpanichnant, Sanya
    Kwong, Yok-Lam
    Ko, Young Hyeh
    Cho, Yung-Tsu
    Chng, Wee Joo
    Matsushita, Takashi
    Yoshino, Tadashi
    Chuang, Shih-Sung
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2015, 39 (01) : 1 - 12
  • [29] The effect of extracorporeal photopheresis alone or in combination therapy on circulating CD4+Foxp3+CD25- T cells in patients with leukemic cutaneous T-cell lymphoma
    Shiue, Lisa H.
    Couturier, Jacob
    Lewis, Dorothy E.
    Wei, Caimiao
    Ni, Xiao
    Duvic, Madeleine
    PHOTODERMATOLOGY PHOTOIMMUNOLOGY & PHOTOMEDICINE, 2015, 31 (04) : 184 - 194
  • [30] Impact of body mass index on the severity of bexarotene-associated hypertriglyceridemia: A post hoc analysis of an open-labeled clinical study of combined bexarotene and phototherapy in Japanese patients with cutaneous T-cell lymphoma
    Sanagawa, Akimasa
    Hayakawa, Tomoaki
    Nishida, Emi
    Yamamoto, Aya
    Ikumi, Kyoko
    Mori, Yukari
    Hotta, Yuji
    Kimura, Kazunori
    Furukawa-Hibi, Yoko
    Morita, Akimichi
    JOURNAL OF DERMATOLOGY, 2023, 50 (07) : 917 - 926
12345